
2-in-1 COVID-flu vaccine looks promising, but approval could be delayed" target="_self" data-before-rewrite-localise="/...
Two might be better than one: A new vaccine that targets the viruses behind seasonal flu and COVID-19 triggers a stronger immune response than flu and COVID shots given separately, trial data suggest. The combination shot, dubbed mRNA-1083, is made by the …